Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Anusol
- Development stage
- Unknown
- Lead developer
- Salix Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Topical, Rectal
01
Overview
Anusol is a medication used for the symptomatic relief of hemorrhoids and other anorectal conditions such as pruritus ani, proctitis, and anal fissures. The standard Anusol formulation contains zinc oxide, bismuth subgallate, balsam peru, and bismuth oxide. Anusol-HC is a variant that contains hydrocortisone acetate, a corticosteroid that helps reduce inflammation. Anusol provides antiseptic, astringent, and emollient properties to relieve discomfort associated with minor anorectal conditions.
- Brand names
- AnusolAnusol-HC
02
Targets
GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on Anusol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anusol.